Co-Diagnostics, Inc. CODX 深 滬
已收盤 05-08 16:00:00 美东时间
2.53
+0.600
+31.09%
華盛通- 最 高2.77
- 今 開2.16
- 成交量 1032.11万股
- 最 低 1.90
- 昨 收 1.93
- 總市值 911.42万
- 52周最高 3.95
- 市盈率 靜 --
- 換手率 286.50%
- 52周最低 1.35
- 委 比 35.99%
- 總股本 360.25万
- 歷史最高 3.95
- 量 比 82.84
- 振 幅 45.08%
- 歷史最低 1.35
- 每 手 1
- 風險率 0.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Co-Diagnostics Announces That Its JV CoMira Diagnostics Finalized A Lease Agreement For Its Planned Manufacturing Facility In Saudi Arabia
he lease execution represents a key milestone as CoMira advances domestic manufacturing capabilities within the KSA and follows the Company's previously announced approval for an industrial land allocation in Sudair
05-08 21:03
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
MTB test on Co-Dx PCR platform* to be presented at roundtable with Stop TB Partnership, U.S. Department of State, and global stakeholders SALT LAKE CITY, April 16, 2026 /PRNewswire/ -- Co-Di...
04-16 21:00
Co-Diagnostics Earnings Call: Pipeline Progress, Cash Strain
Co-Diagnostics (($CODX)) has held its Q4 earnings call. Read on for the main hi...
04-04 08:03
Co-Diagnostics JV CoMira Secures Industrial Land Allocation In Sudair Industrial City In Riyadh Region
Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi ArabiaSALT LAKE CITY, April 2, 2026 /PRNewswire/ --
04-02 21:11
Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY
Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent decrease over losses of $(10.82) per share from the same period last year. The company reported $263.922 thousand in
04-01 04:07
Earnings Scheduled For March 31, 2026
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch
Co-Diagnostics ships PCR Pro and TB test kits to India, advancing clinical studies as the WHO backs NPOC diagnostics.
03-25 19:46
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Azitra (AMEX:AZTR) stock moved upwards by 87.3% to $0.33 during Friday...
03-20 20:05
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity
Co-Diagnostics expands CoSara's reach across South Asia, targeting a $13 billion market and boosting access to rapid diagnostic solutions.
03-20 19:56
Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast
Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast Co-Diagnostics will release its fourth quarter and full year 2025 financial results on March 31, 2026, after the market close. The company will host a conference call and webcast on March 31, 2026 at 4:30 p.m. ET, with
03-17 21:04
